ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2820

Multi-Omics Studies of Gut Microbiota in Enthesitis-Related Arthritis Identify Diminished Microbial Diversity and Altered Typtophan Metabolism As Potential Factors in Disease Pathogenesis

Matthew L. Stoll1, Landon S. Wilson2, Stephen Barnes3, Ranjit Kumar4, Anna Genin5, Randy Q. Cron1, Charles O. Elson6, Casey D Morrow7 and Elliot J. Lefkowitz8, 1Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2Pharmicology / Toxicology, University of Alabama at Birmingham, Birmingham, AL, 3Pharmicology, University of Alabama at Birmingham, Birmingham, AL, 4Center for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL, 5Pediatrics, University of Alabama at Birmingham, Birmingham, AL, 6Dept of Medicine, University of Alabama at Birmingham, Birmingham, AL, 7Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, 8Microbiology, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: metabolomics, microbiome and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Children with enthesitis-related arthritis (ERA) and adults with spondyloarthritis are at risk for intestinal inflammation. We have previously shown altered microbiota in children with ERA similar to inflammatory bowel disease. However, the mechanisms by which an altered microbiota might predispose to arthritis and intestinal inflammation remain unclear. Therefore, we explored expression profiles from fecal samples of children with ERA.

Methods: Fecal samples were obtained from patients with ERA and healthy controls. For metabolomics, samples were subjected to acid extraction and analyzed by nanoscale liquid chromatography coupled to tandem mass spectrometry (MS). Data analysis was performed with the mummichog for metabolomics program on the output of the positive and negative modes MS analyses, comparing metabolites identified by mass : charge ratio with at least a 1.5 fold difference between patients and controls, and a p-value of <0.05. This was repeated on a second cohort of largely newly diagnosed ERA patients and healthy controls. For metagenomics, fecal samples from a subset of the second cohort (10 with ERA & 8 controls) were subject to DNA purification and shotgun sequencing using MiSeq.

Results: The initial metabolomics run involved 12 ERA patients and 11 controls. Among the negative mode ions, pathway analysis revealed 5 pathways relatively under-represented in patients:  metabolism of biopterin, tryptophan, glycerophospholipid, urea cycle, and tyrosine. The repeat run was performed on 15 non-overlapping patients with largely newly diagnosed ERA and 11 controls. Tryptophan metabolism again emerged as under-represented in patients among the negative mode ions, as did the butanoate pathway. Additionally, both runs revealed far more ions over-represented in controls as compared to patients. Metagenomics analysis was generally consistent with the metabolomics: more genes and pathways were represented in the controls compared to patients. In addition, the patients had less taxonomic diversity.

Conclusion: Multi-omics analysis of children with ERA compared to healthy controls indicates lower functional metabolic potential and activity in ERA patients, decreased taxonomic diversity, and  possible differences in the fecal microbial metabolism of tryptophan. Thus, we have identified functional correlates to the diminished microbial diversity seen in many disease states. Also, tryptophan metabolism has been linked to the balance between Th17 and regulatory T cells; thus, it appears that the fecal microbiota may affect T cell development towards a pro- or anti-inflammatory phenotype. This may help to explain findings of intestinal inflammation and arthritis in children with ERA.


Disclosure: M. L. Stoll, None; L. S. Wilson, None; S. Barnes, None; R. Kumar, None; A. Genin, None; R. Q. Cron, None; C. O. Elson, None; C. D. Morrow, None; E. J. Lefkowitz, None.

To cite this abstract in AMA style:

Stoll ML, Wilson LS, Barnes S, Kumar R, Genin A, Cron RQ, Elson CO, Morrow CD, Lefkowitz EJ. Multi-Omics Studies of Gut Microbiota in Enthesitis-Related Arthritis Identify Diminished Microbial Diversity and Altered Typtophan Metabolism As Potential Factors in Disease Pathogenesis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/multi-omics-studies-of-gut-microbiota-in-enthesitis-related-arthritis-identify-diminished-microbial-diversity-and-altered-typtophan-metabolism-as-potential-factors-in-disease-pathogenesis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multi-omics-studies-of-gut-microbiota-in-enthesitis-related-arthritis-identify-diminished-microbial-diversity-and-altered-typtophan-metabolism-as-potential-factors-in-disease-pathogenesis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology